JEIL PHARMA HOLDINGS INC. Logo

JEIL PHARMA HOLDINGS INC.

Develops, manufactures, and distributes pharmaceuticals, APIs, and generic drugs.

002620 | KO

Overview

Corporate Details

ISIN(s):
KR7002620003
LEI:
Country:
South Korea
Address:
서울특별시 서초구 사평대로 343, 서초구

Description

Jeil Pharma Holdings Inc., established in 1959, is a pharmaceutical company engaged in the development, manufacturing, and distribution of medical products. The company's portfolio includes finished pharmaceutical products, active pharmaceutical ingredients (APIs), incrementally modified drugs, and generic drugs. Key product categories include analgesic anti-inflammatories and broad-spectrum oral medications. The company is also focused on developing high-value products and aims to be a leading manufacturer of injection medicines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-05-29 00:00
기업지배구조보고서공시
Korean 923.3 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.7 MB
2025-03-25 00:00
정기주주총회결과
Korean 20.7 KB
2025-03-17 00:00
감사보고서제출
Korean 21.4 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 2.0 MB
2025-03-10 00:00
주주총회소집공고
Korean 987.3 KB
2025-03-05 00:00
현금ㆍ현물배당결정
Korean 9.1 KB
2025-03-05 00:00
주주총회소집결의
Korean 8.6 KB
2025-02-24 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 14.3 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.5 MB
2024-09-23 00:00
[기재정정]기업지배구조보고서공시
Korean 847.3 KB
2024-08-28 00:00
[기재정정]반기보고서 (2024.06)
Korean 1.4 MB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.4 MB
2024-05-30 00:00
기업지배구조보고서공시
Korean 844.4 KB

Automate Your Workflow. Get a real-time feed of all JEIL PHARMA HOLDINGS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JEIL PHARMA HOLDINGS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JEIL PHARMA HOLDINGS INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.